Prev Arrow Stocks

Perrigo Company plc ($PRGO) Stock Forecast: Down 6.6% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is Perrigo Company plc?

Perrigo Company PLC (PRGO) is a pharmaceutical company that focuses on providing affordable healthcare products to consumers. Today, PRGO experienced a strong bearish movement in the stock market.

Why is Perrigo Company plc going down?

PRGO stock is down 6.6% on Jun 18, 2026 14:51

  • The introduction of a new protective case for Perrigo's medical devices, while aiming to enhance safety and convenience for patients and caregivers, did not seem to positively impact the stock price.
  • The routine equity compensation activities reported by Perrigo directors, including RSU exercises and new grants, may have raised concerns among investors about potential dilution or insider sentiment.
  • Perrigo's stock underperformance compared to its competitors on a day when the overall market saw significant gains suggests that company-specific factors may have contributed to the bearish movement.
  • The stock closing significantly below its 52-week high indicates ongoing challenges or lack of positive catalysts for PRGO, leading to investor pessimism and selling pressure.

PRGO Price Chart

PRGO Technical Analysis

PRGO News

New protective case elevates everyday use of Perrigo Company PLC medical devices

Perrigo Company PLC has introduced a new compact and reinforced protective case for its medical devices, designed to enhance safety and convenience for patients and caregivers during daily use. This accessory aims to reduce anxiety by protecting devices from damage and keeping essential components organized, reflecting Perrigo's commitment to supporting the everyday realities of its therapy users. The company views such accessories as crucial for improving patient satisfaction and adherence, thereby strengthening its market role.

https://www.ad-hoc-news.de/boerse/news/ueberblick/new-protective-case-elevates-everyday-use-of-perrigo-company-plc-medical/69558852

0 News Article Image New protective case elevates everyday use of Perrigo Company PLC medical devices

New protective case elevates everyday use of Perrigo Company PLC medical devices

Perrigo Company PLC has introduced a new protective case for its medical devices, designed for daily use by patients and caregivers. The compact, reinforced case aims to enhance safety and convenience, reducing the risk of damage during transport and organizing accessories. This accessory highlights Perrigo's attention to the practical needs of its users, reinforcing trust and adherence to therapy routines.

https://www.ad-hoc-news.de/news/ueberblick/new-protective-case-elevates-everyday-use-of-perrigo-company-plc-medical/69558852

1 News Article Image New protective case elevates everyday use of Perrigo Company PLC medical devices

Perrigo (PRGO) director reports RSU exercise, tax withholding and 844-unit RSU grant

Perrigo Company plc director Geoffrey M. Parker reported routine equity compensation activity. He exercised 976 restricted stock units (RSUs) into ordinary shares, had 469 shares withheld for tax obligations, and received a new grant of 844 RSUs vesting on June 12, 2027. The Form 4 filing details direct and indirect shareholdings, including through a Roth IRA and a revocable trust.

https://www.stocktitan.net/sec-filings/PRGO/form-4-perrigo-co-plc-insider-trading-activity-5f947c2e9042.html

2 News Article Image Perrigo (PRGO) director reports RSU exercise, tax withholding and 844-unit RSU grant

Perrigo (NYSE: PRGO) director logs RSU exercise, tax withholding and 2,559-unit grant

Perrigo Company plc director Bradley A. Alford reported an exercise of 976 Restricted Stock Units (RSUs) into Ordinary Shares, with 469 shares withheld for tax obligations. He also received a new grant of 2,559 RSUs, which will vest on June 12, 2027. Following these transactions, Alford directly holds 45,465.148 Ordinary Shares.

https://www.stocktitan.net/sec-filings/PRGO/form-4-perrigo-co-plc-insider-trading-activity-fc75abfc33a1.html

3 News Article Image Perrigo (NYSE: PRGO) director logs RSU exercise, tax withholding and 2,559-unit grant

Perrigo Co. PLC stock underperforms Monday when compared to competitors

Perrigo Co. PLC (PRGO) stock dropped 2.64% to $10.70 on Monday, underperforming a strong market day where the S&P 500 and Dow Jones Industrial Average both saw significant gains. The company's stock closed 62.37% below its 52-week high of $28.44 reached on July 25th.

https://www.marketwatch.com/data-news/perrigo-co-plc-stock-underperforms-monday-when-compared-to-competitors-015dc1aa-b2e1c89a7280?mod=mw_quote_news

4 News Article Image Perrigo Co. PLC stock underperforms Monday when compared to competitors

Perrigo Company plc Price History

30.03.2026 - PRGO Stock was up 5.0%

  • Perrigo Company plc declared a quarterly dividend of $0.29 per share, continuing its streak of dividend increases for 23 years. This likely increased investor confidence in the company's financial resilience and long-term growth potential.
  • Despite a recent earnings shortfall, analysts predict Perrigo will maintain dividend coverage with future earnings, showing strength in overcoming short-term obstacles.
  • An upgrade in Perrigo's stock rating from a "strong sell" to a "hold" by Zacks Research, along with revised EPS estimates, indicates a positive outlook for the company. This could have led to the stock price's upward momentum.
  • The announcement of the dividend, enhanced analyst rating, and strategic focus on consumer health solutions are probable catalysts for Perrigo's positive performance in the market today.

11.05.2026 - PRGO Stock was down 5.3%

  • The recent uptick in takeover speculations and the CEO's resignation have possibly led to uncertainty and a pessimistic mood among investors, resulting in a downward trend in PRGO stock.
  • Actions such as the ex-CEO and other executives exercising RSUs, coupled with the company's confirmation of its financial outlook for FY 2026, may have contributed to the stock experiencing selling pressure.
  • Despite potential interest in a takeover, challenges within the consumer healthcare sector and the management transition seem to have outweighed any positive developments, prompting investors to react with negativity towards PRGO's stock.

08.05.2026 - PRGO Stock was up 5.1%

  • Despite falling short of revenue expectations, Perrigo's stock rose by nearly 5% following an earnings beat, indicating positive investor sentiment towards the company's performance.
  • The market has reacted favorably to Perrigo's decision to divest its Dermacosmetics business as a strategic move to reduce debt, signaling a step towards financial stability.
  • Perrigo's recent stock performance lagging behind its competitors and the broader market may be due to concerns regarding its high leverage, challenged balance sheet, and unsustainable dividend yield.
  • Perrigo faces uncertainty in its long-term prospects and needs to prioritize debt reduction, streamline its product portfolio, and improve cash flow to rebuild investor confidence and solidify its financial standing.

08.05.2026 - PRGO Stock was up 5.8%

  • PRGO's stock showed a strong 5% rise following positive earnings despite a revenue shortfall, indicating strong investor confidence.
  • The company's strategic asset sales to reduce debt and its maintenance of full-year guidance have positively affected market sentiment towards PRGO.
  • Although PRGO has lagged behind its competitors and faced consecutive days of losses, the recent upbeat earnings report and financial strengthening efforts might offset these challenges.
  • Investor optimism and the bullish movement in PRGO's stock today could be influenced by AI-generated analysis pointing to possible growth opportunities and stable neutral outlooks in the short term.

15.05.2026 - PRGO Stock was down 5.0%

  • Perrigo's stock showed poor performance compared to competitors and broader market indexes, with the third day of losses. Reasons could include:
  • The CEO's resignation due to personal conduct violations, raising concerns about operational disruption and uncertainty.
  • Despite an interim CEO appointment and reaffirmed financial outlook, worries surrounding financial performance, such as significant losses and decreasing revenue, may have unsettled investors.
  • Speculation about a potential takeover, initially boosting the stock price, likely intensified volatility and uncertainty in its movement, impacting investor sentiment negatively.
  • While routine equity compensation transactions by Perrigo's EVP were not directly linked to the bearish movement, they might have contributed to market noise and sentiment surrounding the stock.

18.05.2026 - PRGO Stock was down 6.6%

  • The introduction of a new protective case for Perrigo's medical devices, while aiming to enhance safety and convenience for patients and caregivers, did not seem to positively impact the stock price.
  • The routine equity compensation activities reported by Perrigo directors, including RSU exercises and new grants, may have raised concerns among investors about potential dilution or insider sentiment.
  • Perrigo's stock underperformance compared to its competitors on a day when the overall market saw significant gains suggests that company-specific factors may have contributed to the bearish movement.
  • The stock closing significantly below its 52-week high indicates ongoing challenges or lack of positive catalysts for PRGO, leading to investor pessimism and selling pressure.

17.05.2026 - PRGO Stock was down 5.9%

  • The introduction of a new protective case for its medical devices may not have been enough to offset investor concerns about the company's overall performance, leading to the bearish movement.
  • The routine equity compensation activities of the company's directors, while normal, may have raised questions about the company's financial health and stability in the eyes of investors.
  • PRGO's underperformance compared to its competitors on multiple days, despite a positive market environment, could indicate underlying issues within the company that are causing investors to lose confidence in its stock.
  • The continuous downward trend in PRGO's stock price, closing significantly below its 52-week high, suggests that investors may be worried about the company's future growth prospects and financial outlook.

06.04.2026 - PRGO Stock was up 7.6%

  • Perrigo Company reported Q1 2026 financial results, with adjusted earnings of $0.43 per share, surpassing expectations. This positive earnings surprise likely contributed to the bullish movement in PRGO stock.
  • Despite a 7.2% decrease in revenue year-over-year, the company's adjusted EPS exceeding estimates and the optimistic FY 2026 earnings guidance of $2.00 to $2.30 per share and revenues between $4.0 billion and $4.2 billion provided a strong outlook for investors.
  • The announcement of a quarterly dividend of $0.29 per share, with an annualized yield of 10.0%, could have also attracted investors seeking income opportunities, further boosting PRGO's stock performance.
  • Overall, the combination of better-than-expected earnings, positive future guidance, and the dividend announcement likely fueled investor confidence in Perrigo Company, leading to the bullish market movement.

06.04.2026 - PRGO Stock was up 5.4%

  • Perrigo's positive market movement is linked to strong shareholder backing and confidence in the company's governance and financial adaptability. This is evident from the re-election of directors, approval of executive pay, and endorsement of the 2026 equity plan.
  • Approval of the new 2026 Long-Term Incentive Plan and other proposals by shareholders points towards an optimistic view on the company's future growth and strategic endeavors.
  • Despite projections of a decline in EPS and revenue for Q1 2026, investors are hopeful about Perrigo's cost-saving measures and restructuring attempts to generate long-term value.
  • The ongoing investigation regarding potential misconduct by company officials may have caused initial concerns, but positive shareholder sentiment and strategic choices appear to have overshadowed these uncertainties, steering Perrigo's favorable market performance today.

12.05.2026 - PRGO Stock was up 5.7%

  • A CEO resignation over personal conduct issues and the appointment of an interim CEO initially caused uncertainty but later reassured investors about the company's financial outlook.
  • Speculation about potential takeovers by outside companies boosted investor optimism and interest in PRGO's future.
  • Executives at PRGO engaging in routine equity compensation transactions, with the former CEO exercising RSUs, possibly indicated confidence in the company's performance.
  • Despite challenges like category weakness and pressures in the infant formula sector, the company's leadership changes and growth projections in private-label business could be viewed positively by investors, fueling the bullish market movement for PRGO.

11.04.2026 - PRGO Stock was down 5.0%

  • Perrigo Company plc (PRGO) experienced a strong bearish movement today, closing down 4.40% at $11.72.
  • Despite beating earnings estimates with an adjusted EPS of $0.43 per share in Q1, Perrigo's revenue of $969.2 million fell short of expectations, contributing to the stock's decline.
  • The challenging market conditions, retailer inventory destocking, and revenue miss likely weighed on investor sentiment, leading to the bearish movement in the stock.
  • Vanguard Group Inc.'s increased stake in the company may indicate long-term confidence, but short-term market factors and revenue concerns seem to have driven the stock price down today.

09.05.2026 - PRGO Stock was down 5.3%

  • The sudden resignation of Perrigo's CEO, Patrick Lockwood-Taylor, due to personal conduct violations likely led to uncertainty and concern among investors, contributing to the bearish movement in the stock.
  • The appointment of Albert A. Manzone as Interim President and CEO may have added to the market's unease, as leadership transitions can introduce instability and impact investor confidence.
  • Despite the leadership changes, Perrigo's reaffirmation of its full-year 2026 financial guidance could provide some reassurance to investors, indicating that the company remains committed to its strategic objectives and operational performance.
  • The reported RSU exercise and share disposition by EVP and CSO Abigail Lennox, while primarily related to equity compensation and tax obligations, might have also played a minor role in the stock's downward movement.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.